DBV Technologies | DBVT - Trade Debtors


DBV Technologies reported $15.97M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amarin USD 126.83M 477K Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
DBV Technologies USD 15.97M 279K Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Insmed USD 178.55M 37.7M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026